However, DBS isn’t a magic solution. Rather, it is like a cast for a broken leg; people with depression are still encouraged ...
6d
Medical Device Network on MSNAbbott’s brain stimulation trial for depression kicks off at Mount SinaiNew York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...
10d
News-Medical.Net on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.
A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...
Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...
Bhubaneswar: In a groundbreaking achievement, the Institute of Medical Sciences and SUM Hospital has succesfully conducted ...
There is no cure for debilitating neurological conditions like Parkinson's, however, deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other neurological ...
Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
In the fifth episode of The Deep End, volunteers describe what it’s like to live with the stigma of depression and the treatments they seek for it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results